Amgen Settles Patent Lawsuit Over Biosimilar of Stelara Amgen Settles Patent Lawsuit Over Biosimilar of Stelara

Johnson& Johnson has settled its lawsuit over Amgen ' s proposed biosimilar version of J&J ' s top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.Reuters Health Information
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news